Hematopoietic cytokine receptor signaling

被引:204
作者
Baker, S. J.
Rane, S. G.
Reddy, E. P.
机构
[1] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA
[2] NIDDK, NIH, Diabet Branch, Bethesda, MD USA
关键词
hematopoiesis; cytokine receptors; Src kinases; JAKs; STATs;
D O I
10.1038/sj.onc.1210757
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hematopoiesis is the cumulative result of intricately regulated signaling pathways that are mediated by cytokines and their receptors. Proper culmination of these diverse pathways forms the basis for an orderly generation of different cell types. Recent studies conducted over the past 10 - 15 years have revealed that hematopoietic cytokine receptor signaling is largely mediated by a family of tyrosine kinases termed Janus kinases ( JAKs) and their downstream transcription factors termed STATs ( signal transducers and activators of transcription). Aberration in these pathways, such as that caused by the recently identified JAK2V617F mutation, is an underlying cause for diseases such as leukemias and other myeloproliferative disorders. This recent discovery, when coupled with the fact that STATs are activated by oncoproteins such as BCR-ABL, underscores the importance of the JAK- STAT pathway in both normal cellular development and disease states.
引用
收藏
页码:6724 / 6737
页数:14
相关论文
共 130 条
  • [51] Protein kinase C δ associates with and phosphorylates Stat3 in an interleukin-6-dependent manner
    Jain, N
    Zhang, T
    Kee, WH
    Li, WQ
    Cao, XM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (34) : 24392 - 24400
  • [52] Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK)
    Jain, N
    Zhang, T
    Fong, SL
    Lim, CP
    Cao, XM
    [J]. ONCOGENE, 1998, 17 (24) : 3157 - 3167
  • [53] A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
    James, C
    Ugo, V
    Le Couédic, JP
    Staerk, J
    Delhommeau, F
    Lacout, C
    Garçon, L
    Raslova, H
    Berger, R
    Bennaceur-Griscelli, A
    Villeval, JL
    Constantinescu, SN
    Casadevall, N
    Vainchenker, W
    [J]. NATURE, 2005, 434 (7037) : 1144 - 1148
  • [54] Jiao HY, 1996, MOL CELL BIOL, V16, P6985
  • [55] JUBINSKY PT, 1993, BLOOD, V81, P587
  • [56] Computational and functional analysis of the putative SH2 domain in Janus Kinases
    Kampa, D
    Burnside, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 278 (01) : 175 - 182
  • [57] MOLECULAR-CLONING OF L-JAK, A JANUS FAMILY PROTEIN-TYROSINE KINASE EXPRESSED IN NATURAL-KILLER-CELLS AND ACTIVATED LEUKOCYTES
    KAWAMURA, M
    MCVICAR, DW
    JOHNSTON, JA
    BLAKE, TB
    CHEN, YQ
    LAL, BK
    LLOYD, AR
    KELVIN, DJ
    STAPLES, JE
    ORTALDO, JR
    OSHEA, JJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (14) : 6374 - 6378
  • [58] Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A
    Kazansky, AV
    Kabotyanski, EB
    Wyszomierski, SL
    Mancini, MA
    Rosen, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (32) : 22484 - 22492
  • [59] The role of Janus kinases in haemopoiesis and haematological malignancy
    Khwaja, Asim
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (04) : 366 - 384
  • [60] CYTOKINE SIGNAL-TRANSDUCTION
    KISHIMOTO, T
    TAGA, T
    AKIRA, S
    [J]. CELL, 1994, 76 (02) : 253 - 262